Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine.
The use of anabolic androgenic steroids (AAS) has been associated with different adverse effects, some of which potentially lethal. Most users of AAS are male, but the prevalence of such use appears to be increasing in females. Here we present a sudden unexpected death in a female fitness athlete with a possible connection to use of doping agents.
Thiblin
I
I
Dept of Forensic Medicine, Uppsala University, SE-752 37 Uppsala, Sweden. Ingemar.thiblin@surgsci.uu.se
Mobini-Far
H
H
Frisk
M
M
D000311:Adrenal Glands / Q000473:pathology; D000328:Adult; D045930:Anabolic Agents / Q000652:urine; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000097:blood*; D003645:Death, Sudden / Q000209:etiology*; D004300:Doping in Sports; D004809:Ephedrine / Q000009:adverse effects / Q000097:blood*; D004845:Epitestosterone / Q000097:blood; D005260:Female; D053593:Forensic Toxicology; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D008168:Lung / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D010665:Phenylpropanolamine / Q000009:adverse effects / Q000097:blood*; D013197:Stanozolol / Q000652:urine; D013566:Sympathomimetics / Q000009:adverse effects / Q000097:blood*; D013739:Testosterone / Q000031:analogs & derivatives / Q000652:urine
D045930:Anabolic Agents; D000697:Central Nervous System Stimulants; D013566:Sympathomimetics; D010665:Phenylpropanolamine; D013739:Testosterone; D004845:Epitestosterone; D013197:Stanozolol; C013915:boldenone; D004809:Ephedrine